NBIX — NEUROCRINE BIOSCIENCES INC
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 914475 ·
Last close
$165.24
Market Cap
$16.61B
52W High
$169.57
52W Low
$125.11
ADV30
1,258,416
Next earnings
2026-07-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 814,500,000 | 800,700,000 | 186,000,000 | 197,900,000 | 4,906,200,000 | 266,500,000 | 1,498,800,000 |
| Dec 2025 | 805,500,000 | 787,900,000 | 227,900,000 | 153,700,000 | 4,631,500,000 | 713,000,000 | 1,378,400,000 |
| Sep 2025 | 794,900,000 | 780,900,000 | 239,300,000 | 209,500,000 | 4,265,700,000 | 340,200,000 | 1,262,100,000 |
| Jun 2025 | 687,500,000 | 676,200,000 | 145,600,000 | 107,500,000 | 3,889,800,000 | 264,000,000 | 1,195,500,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$863,700,000
Investing CF
$-784,800,000
Financing CF
$-6,500,000
CapEx
$-45,500,000
Dividends Paid
—
Buybacks
$-71,700,000
EPS Diluted TTM
$6.49
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$589,600,000
Inventory
$64,500,000
Receivables
$768,100,000
ST Investments
$1,049,700,000
EBIT TTM
$798,800,000
Pretax Income TTM
$937,500,000
Interest Exp TTM
—
Analysts
27
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,102,400,000
EBITDA
$828,600,000
Free Cash Flow
$590,550,016
Enterprise Value
$15,549,012,992
Total Cash
$1,316,199,936
Total Debt
$463,500,000
Shares Out
100,549,983
Trailing EPS
$6.49
Book Value
$33.87
ROE
22.5%
ROA
11.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,860,500,000 | 636,500,000 | 478,600,000 | 4,631,500,000 | 1,378,400,000 | — | 782,700,000 |
| Dec 2024 | 2,355,300,000 | 583,000,000 | 341,300,000 | 3,718,700,000 | 1,129,000,000 | — | 595,400,000 |
| Dec 2023 | 1,887,100,000 | 394,800,000 | 249,700,000 | 3,251,400,000 | 1,019,400,000 | — | 389,900,000 |
| Dec 2022 | 1,488,700,000 | 249,000,000 | 154,500,000 | 2,368,700,000 | 660,900,000 | — | 339,400,000 |
TTM Snapshot
Revenues TTM
$1,804,800,000
NetIncome TTM
$303,900,000
OpCashFlow TTM
$0
Assets (Latest)
$3,718,700,000
Forward EPS
$12.71
Max Pain — expiry 2026-12-18
max pain strike: $160.00 · spot: $165.24 · call oi: 106 · put oi: 1,609Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MRNA | Moderna, Inc. | $18.94B | $47.73 | — |
| EXEL | EXELIXIS, INC. | $13.32B | $52.99 | — |
| BNTX | BioNTech SE | $21.87B | $86.50 | — |
| BIIB | BIOGEN INC. | $29.39B | $199.10 | — |
| KRYS | Krystal Biotech, Inc. | $9.13B | $309.75 | — |
News headlines (Yahoo Finance, 1h cache)
Neurocrine Biosciences Presents New Clinically Meaningful Response Data on Treatment of Tardive Dyskinesia, Reinforcing the Efficacy of INGREZZA® (valbenazine) Capsules Across a Broad Range of Patient
2026-06-08 20:05 · Yahoo
Neurocrine Biosciences Presents New Data Highlighting Functional and Socio-emotional Improvements with INGREZZA® (valbenazine) Capsules in Individuals with Tardive Dyskinesia and Intellectual and Deve
2026-06-08 12:30 · Yahoo
Assessing Neurocrine Biosciences (NBIX) Valuation After Recent Share Price Momentum
2026-06-05 04:50 · Yahoo
RBC Capital Raises its Price Target on Neurocrine Biosciences (NBIX)
2026-06-04 16:49 · Yahoo
Dow Jones Futures Rise, But Broadcom, CrowdStrike, Ciena Hit Techs; SpaceX IPO Price Target Set
2026-06-04 12:06 · Yahoo
Neurocrine Biosciences to Present New Two‑Year CRENESSITY® (crinecerfont) Data on Key Clinical and Patient‑Reported Outcome Measures at ENDO 2026
2026-06-03 12:30 · Yahoo
Meta Platforms upgraded, Okta downgraded: Wall Street's top analyst calls
2026-06-02 13:43 · Yahoo
Centene, Deckers and 14 Other ‘Dividend Hopefuls’
2026-06-02 05:30 · Yahoo
Neurocrine Biosciences Should See More Upside on Crenessity Growth, RBC Says
2026-05-29 16:21 · Yahoo
Neurocrine Biosciences to Present at Upcoming Investor Conferences in June
2026-05-26 20:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.